Cell Death Pathways in Mutant Rhodopsin Rat Models Identifies Genotype-Specific Targets Controlling Retinal Degeneration

作者: Ishaq A. Viringipurampeer , Cheryl Y. Gregory-Evans , Andrew L. Metcalfe , Emran Bashar , Orson L. Moritz

DOI: 10.1007/S12035-018-1192-8

关键词: Cell biologyNecroptosisPhotoreceptor cellProgrammed cell deathRetinitis pigmentosaBiologyCone cellRhodopsinRetinal degenerationRod cell

摘要: Retinitis pigmentosa (RP) is a group of inherited neurological disorders characterized by rod photoreceptor cell death, followed secondary cone death leading to progressive blindness. Currently, there are no viable treatment options for RP. Due incomplete knowledge the molecular signaling pathways associated with RP pathogenesis, designing therapeutic strategies remains challenge. In particular, preventing loss key goal in potential therapies. this study, we identified main drivers and transgenic S334ter rhodopsin rat model, tested efficacy specific inhibitors on retinal function, compared effect combining drugs target multiple P23H models. The primary driver early model was caspase-dependent process, whereas occurred though RIP3-dependent necroptosis. comparison, via necroptotic signaling, through inflammasome activation. Combination therapy four worked better than individual but not model. These differences imply that modalities need be tailored each genotype. Taken together, our data demonstrate rationally designed genotype-specific drug combinations will an important requisite effectively more importantly survival.

参考文章(66)
Steven C. Minear, Vincent T. Ciavatta, Sheree S. Sidney, Clifford J. Steer, Jeffrey H. Boatright, Vi T. Do, John M. Nickerson, Michael J. Phillips, Bo Chang, Machelle T. Pardue, Amber P. Boyd, Cecilia M.P. Rodrigues, Rachael E. Stewart, Anisha G. Moring, Norm L. Hawes, Clinton McElroy, Rajashree Chaudhury, Tool from ancient pharmacopoeia prevents vision loss Molecular Vision. ,vol. 12, pp. 1706- 1714 ,(2006)
Matthew M LaVail, Michael T Matthes, Douglas Yasumura, Mark McClellan, Maureen B Maude, Robert E Anderson, Low docosahexaenoic acid levels in rod outer segments of rats with P23H and S334ter rhodopsin mutations. Molecular Vision. ,vol. 8, pp. 351- ,(2002)
E L Berson, Retinitis pigmentosa. The Friedenwald Lecture. Investigative Ophthalmology & Visual Science. ,vol. 34, pp. 1659- 1676 ,(1993)
Elise Orhan, Deniz Dalkara, Marion Neuillé, Christophe Lechauve, Christelle Michiels, Serge Picaud, Thierry Léveillard, José-Alain Sahel, Muna I. Naash, Matthew M. Lavail, Christina Zeitz, Isabelle Audo, Genotypic and Phenotypic Characterization of P23H Line 1 Rat Model PLOS ONE. ,vol. 10, pp. e0127319- ,(2015) , 10.1371/JOURNAL.PONE.0127319
Claudine Versaux-Botteri, Jacques Callebert, Marguerite Wasowicz, Patricia Ferrari, Cécile Morice, Long-Term Effects of Light Damage on the Retina of Albino and Pigmented Rats Investigative Ophthalmology & Visual Science. ,vol. 43, pp. 813- 820 ,(2002)
Eliot L. Berson, Carol Weigel-DiFranco, Michael A. Sandberg, Thaddeus P. Dryja, Clinical Expression Correlates With Location of Rhodopsin Mutation in Dominant Retinitis Pigmentosa Investigative Ophthalmology & Visual Science. ,vol. 36, pp. 1934- 1942 ,(1995)
Matthew M. LaVail, Michael D. Menz, Eric S. Green, John G. Flannery, Characterization of rhodopsin mis-sorting and constitutive activation in a transgenic rat model of retinitis pigmentosa. Investigative Ophthalmology & Visual Science. ,vol. 41, pp. 1546- 1553 ,(2000)
Paolo Reboldi, Gentile, Angeli, Verdecchia, Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials Vascular Health and Risk Management. ,vol. 5, pp. 411- 427 ,(2009) , 10.2147/VHRM.S4235
Richard S. Saliba, Peter M. G. Munro, Michael E. Cheetham, Philip J. Luthert, The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation Journal of Cell Science. ,vol. 115, pp. 2907- 2918 ,(2002) , 10.1242/JCS.115.14.2907